This compound is a pharmaceutical intermediate specifically used in the manufacturing of ledipasvir. It is a protected amino acid derivative featuring a bicyclic azabicycloheptane core.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 291775-59-2
(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate
Pharmaceutical intermediate for ledipasvir
Ledipasvir Intermediate
Pharmaceutical intermediate for ledipasvir
N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-N-(3-((2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)amino)-3-oxopropyl)acrylamide
research compound
4-CYANOBIPHENYL
Pharmaceutical intermediate synthesis
2'-Deoxyadenosine 5'-monophosphate sodium
pharmaceutical intermediate
DMTr-2'-O-C22-rU-3'-CE-Phosphoramidite
Modified uridine phosphoramidite for oligonucleotide synthesis
(1R,3S,4S)-2-[(2-methylpropan-2-yl)oxycarbonyl]-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
IFAMSTPTNRJBRG-YIZRAAEISA-N
CC(C)(C)OC(=O)N1[C@@H]2CC[C@@H](C2)[C@H]1C(=O)O